对听力损失的药理方法
Christopher R Cederroth1, Jonas Dyhrfjeld-Johnsen1, Barbara Canlon2
1Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden (C.R.C., B.C.); Translational Hearing Research, Tübingen Hearing Research Center, Department of Otolaryngology, Head and Neck Surgery, University of Tübingen, Tübingen, Germany (C.R.C.); and Acousia Therapeutics GmbH, Tübingen, Germany (J.D.-J.).
Pharmacological reviews
|August 20, 2024
概括
新的药理学策略对于治疗听力障碍至关重要. 对分子原因,药物输送和时代药理学的研究表明,更有效的听力损失治疗方法具有前景.
科学领域:
- 药理学 药理学是指药理学的学科.
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 遗传学 是一个遗传学.
背景情况:
- 听力障碍严重影响生活质量,药物治疗方法有限.
- 目前的干预措施主要集中在辅助设备和疗法上,创造了基于药物的解决方案的需求.
- 了解听力损失的分子和细胞机制正在推动药物开发.
研究的目的:
- 突出了对治疗听力障碍的先进药理学方法的迫切需要.
- 探索了解听力损失的遗传和分子基础的最新进展.
- 讨论新药输送和慢药学策略的潜力,以改善治疗结果.
主要方法:
- 关于听力障碍 (噪音,衰老,耳毒性) 的分子和细胞机制的当前研究的综述.
- 对药物输送系统的进步进行分析,以针对耳部药物治疗.
- 在动物模型中检查大型基因组研究和分子技术,以了解病因学.
- 研究听力系统中昼夜节律及其对治疗时间的影响.
主要成果:
- 在了解听力损失的遗传和分子基础方面取得了重大进展.
- 从探索新的药理干预措施的临床试验中得到的有希望的结果.
- 有证据支持针对性耳治疗的增强药物输送.
- 临床前数据表明,慢性药理学方法可以提高治疗的疗效和安全性.
结论:
- 关于分子/遗传基础,药物输送和时间的持续研究为更有效的听力障碍治疗提供了希望.
- 将遗传洞察力与先进的药物配方和输送相结合,可以彻底改变听力损失治疗.
- 慢药学策略,如果翻译,可以优化临床试验结果和患者的好处.
相关概念视频
01:26Neurochemical Transmission: Sites of Drug Action
2.2K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.2K
01:31Hearing
52.0K
When we hear a sound, our nervous system is detecting sound waves—pressure waves of mechanical energy traveling through a medium. The frequency of the wave is perceived as pitch, while the amplitude is perceived as loudness.
52.0K
01:26Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
01:20Desensitization and Tachyphylaxis
1.6K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.6K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
405
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405
01:15Auditory Pathway
5.3K
Auditory pathways constitute the complex neural circuits responsible for transmitting and interpreting auditory information from the peripheral auditory system to the brain. Sound waves are initially captured by the outer ear, funneled through the ear canal, and reach the tympanic membrane (eardrum). These vibrations are transmitted via the middle ear's ossicles to the inner ear's cochlea.
When viewed cross-sectionally, the cochlea reveals the scala vestibuli and scala tympani flanking...
When viewed cross-sectionally, the cochlea reveals the scala vestibuli and scala tympani flanking...
5.3K